Developer docs
API playgroundTry for free, no card

Search company profiles

SweetSpot

Full company profile

uuid0000kcr

Namestring
SweetSpot
Legal namestring
Aegis Digital Health
Company typeenum
Private
Founded yearint
2021
Descriptiontext

SweetSpot is a digital health company, operated by Aegis Digital Health (founded 2021 as a BioGenerator spinout), that delivers remote diabetes monitoring to endocrinology practices across the United States. Its core platform aggregates continuous glucose monitor (CGM) and insulin pump data from all major device manufacturers — including direct integrations with Eversense 365 (Senseonics/Ascensia) and iLet Bionic Pancreas (Beta Bionics) — into a single clinical dashboard where patients are triaged by Glycemia Risk Index (GRI), time in range, and a proprietary 'Sort by Change' capability that identifies patients whose glycemic status is rapidly deteriorating. The platform combines this software layer with wrap-around clinical services delivered by a team of Certified Diabetes Care and Education Specialists (CDCES), who perform monthly data reviews, patient outreach, and treatment coordination on behalf of the practice.

The business model is a no-upfront-fee practice partnership: SweetSpot charges no setup or monthly subscription, instead enabling practices to capture Remote Patient Monitoring (RPM) reimbursement through automated CPT code billing capture built into the platform. This aligns SweetSpot's revenue with the per-patient economics of remote care, which the company cites as roughly $1,000 in annual practice revenue per enrolled patient. Named partners include Jefferson City Medical Group (JCMG), DGD Clinic in San Antonio, and Diabetes & Endocrinology Specialists in Missouri; the company reports supporting thousands of patients nationwide as of late 2025. The leadership team combines clinical and commercial depth — CEO Stephen Von Rump (five-time CEO in health tech), CMO Dr. Ralph Oiknine (board-certified endocrinologist), CCO Abigail Cohen (Forbes 30 Under 30 Healthcare 2017), and board members including Dr. Mary Jo Gorman, founder of Advanced ICU Care.

As of September 2025, SweetSpot had reached $2M in annual recurring revenue and raised over $4M cumulatively, including a $1M+ seed round led by Cultivation Capital and a $4M round from BioGenerator and Cultivation Capital in January 2026. The company is positioning for a Series A in mid-2026 and has signaled continued expansion via a February 2026 strategic partnership with CCS (chronic care management platform) and ongoing AI feature development funded by the 2025 seed round.

Short descriptiontext

SweetSpot (Aegis Digital Health) provides a remote diabetes monitoring platform that aggregates CGM and insulin pump data into a unified dashboard, paired with CDCES-led clinical support services for endocrinology practices on a no-upfront-fee, reimbursement-aligned model.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSt Louis, United States
HQ citystring
St Louis
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
remote diabetes monitoring, CGM data management, endocrinology software platform, virtual clinical support, insulin pump integration
Industry2 codes
PRIMARYHLACAFAA
Chronic Disease RPM Platforms (Diabetes/HTN/COPD/CHF)
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLACAFAI
Care Coordination, Escalation & Clinical Workflow for RPM
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
Product category
Remote Patient Monitoring Software
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Remote Patient Monitoring Reimbursement
TypeSubscription Recurring
Description

SweetSpot enables practices to capture reimbursable care events through automated CPT code utilization. Most health insurers including Medicare pay for monthly reviews and interpretation of patient glucose data. The platform automates data collection, review, and billing processes to unlock new revenue streams for practices.

sweetspot.health
2Clinical Support Services
TypeManaged Services
Description

Provides virtual team of Certified Diabetes Care and Education Specialists (CDCES) who perform monthly CGM data reviews and coordinate with providers on treatment plan changes. This wrap-around service is included in the practice partnership with no set-up or monthly subscription fees for providers.

sweetspot.health
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
Pricing details1 tier
1Practice Partnership - No upfront cost model
ModelSubscriptionBilling cadenceMonthly
Notes

No set-up fee or monthly subscription fee for partnering with SweetSpot to transform diabetes management. Practices generate revenue through reimbursable remote monitoring CPT codes captured by the platform.

sweetspot.health
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

SweetSpot delivers a centralized software platform that aggregates continuous glucose monitor (CGM) and insulin pump data into a unified dashboard for endocrinology practices, combined with wrap-around virtual clinical support from Certified Diabetes Care and Education Specialists (CDCES) who conduct monthly data reviews, patient outreach, and treatment coordination. The platform enables practices to remotely monitor diabetes patients between visits, capture reimbursable remote care events through automated billing, and triage patients by change in Glycemia Risk Index.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 9 values shown
  • 10%+ average improvement in Time in Range (TIR) per patient
+8 more records
Product overview1 text field

SweetSpot is a digital health platform combining centralized diabetes device data management software with virtual clinical support services. The core SweetSpot Remote Diabetes Monitoring Platform aggregates CGM and insulin pump data into a unified dashboard, which is paired with the SweetSpot Clinical Support Services module providing CDCES-led monthly data reviews, patient outreach, and treatment coordination. Additional modules include the Dashboard with Glycemia Risk Index (GRI) triage capabilities and Automated Billing Capture for reimbursement optimization. The platform integrates with major diabetes devices including Eversense 365, iLet Bionic Pancreas, and all major CGMs and insulin pumps.

Product and service2 records
1SweetSpot Remote Diabetes Monitoring Platform
CategoryRemote Patient Monitoring Software
Description

A centralized software platform that aggregates and manages diabetes device data from continuous glucose monitors (CGMs) and insulin pumps, providing endocrinology practices with a single dashboard view of all patient data for remote monitoring between office visits. The platform integrates with all major CGMs and insulin pumps (including Eversense 365 and iLet Bionic Pancreas) and includes GRI-based triage, automated notes summary, and automated billing capture.

2SweetSpot Clinical Support Services
CategoryVirtual Clinical Services
Description

Wrap-around virtual clinical support services provided by a team of Certified Diabetes Care and Education Specialists (CDCES) who perform monthly CGM data reviews, patient outreach between visits, device troubleshooting, and coordinate treatment plan changes with the practice's providers. Delivered as part of the SweetSpot practice partnership with no set-up or monthly subscription fees to the practice.

Scale indicator16 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-10
Description

Strategic partnership with CCS, a Florida-based chronic care management platform and provider of clinical solutions and home-delivered medical supplies for chronic conditions. The partnership connects SweetSpot's clinical team with CCS for supplies like CGM sensors, creating a coordinated feedback loop between platforms. SweetSpot's clinical team can directly connect patients experiencing adherence issues with CCS, leveraging CCS's national reach among private practices and AI capabilities like PropheSee adherence prediction tool. A pilot program launched in select U.S. markets in early 2026.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-01-01
Description

Integration with iLet Bionic Pancreas from Beta Bionics. Device data flows directly into SweetSpot, viewable and manageable alongside other patients' information without separate logins or manual workarounds. This integration simplifies workflow for clinical teams managing patients on the iLet device.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-02-26
Description

Software integration between SweetSpot and Eversense 365, the world's first and only One Year CGM system. The integration provides endocrinology practices partnering with SweetSpot the ability to seamlessly and regularly review data from patients using Eversense 365, allowing for more personalized support between scheduled appointments.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Glooko provides a unified diabetes data management platform that aggregates data from most major CGMs, insulin pumps, and blood glucose meters for clinicians and patients—directly overlapping SweetSpot's core device-aggregation and remote-monitoring workflow for endocrinology practices.

TypeDirect peer
Description

Tidepool is a nonprofit diabetes data platform offering clinician-facing dashboards and reports across multiple CGM and pump devices. It overlaps with SweetSpot on multi-device data aggregation and clinical review, though it has not focused on reimbursement-bundled services.

TypeDirect peer
Description

mySugr, owned by Roche, offers a diabetes self-management app paired with clinician tools and is integrated with Roche's Accu-Chek ecosystem. It competes with SweetSpot for the same endocrinology practice relationships, especially in CGM-data review and patient engagement.

TypeDirect peer
Description

WellDoc's BlueStar is an FDA-cleared digital therapeutic for diabetes that delivers coaching and decision support to patients and integrates with clinician workflows—a directly comparable diabetes digital therapeutics and remote-care platform.

TypeDirect peer
Description

Virta Health is a virtual diabetes clinic combining continuous remote monitoring with clinician coaching to reverse type 2 diabetes. It targets the same payer/employer and endocrinology ecosystem and competes for remote-care reimbursement dollars.

TypeDirect peer
Description

Omada Health offers a virtual chronic-care platform including diabetes management with connected device integration, coaching, and reimbursement-based programs—closely matching SweetSpot's RPM-plus-coaching model for endocrinology and primary care.

TypeDirect peer
Description

Vida Health provides a virtual chronic-condition management platform spanning diabetes, hypertension, and mental health, with connected device integration and coaching—overlapping SweetSpot on RPM-led diabetes care for employer and payer populations.

8Onduo (Verily)
TypeDirect peer
Description

Onduo, part of Verily (Alphabet), is a virtual diabetes management program that combines CGM data with clinician coaching—targeting the same remote-monitoring and reimbursement-driven diabetes care segment as SweetSpot.

TypeBroad incumbent
Description

Livongo, acquired by Teladoc, pioneered the connected CGM-plus-coaching diabetes program at scale and is now part of a much broader chronic-care portfolio. It is the category-defining incumbent against which all diabetes RPM entrants like SweetSpot are benchmarked.

TypeBroad incumbent
Description

Dexcom Clarity is the CGM manufacturer's own clinician analytics platform, aggregating Dexcom device data with reports for endocrinology practices. As a vertically integrated device-maker offering, it represents a structural competitive threat to SweetSpot's device-aggregation layer.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SweetSpot

Remote Patient Monitoring Softwaresweetspot.health

SweetSpot (Aegis Digital Health) provides a remote diabetes monitoring platform that aggregates CGM and insulin pump data into a unified dashboard, paired with CDCES-led clinical support services for endocrinology practices on a no-upfront-fee, reimbursement-aligned model.

What SweetSpot does

SweetSpot is a digital health company, operated by Aegis Digital Health (founded 2021 as a BioGenerator spinout), that delivers remote diabetes monitoring to endocrinology practices across the United States. Its core platform aggregates continuous glucose monitor (CGM) and insulin pump data from all major device manufacturers — including direct integrations with Eversense 365 (Senseonics/Ascensia) and iLet Bionic Pancreas (Beta Bionics) — into a single clinical dashboard where patients are triaged by Glycemia Risk Index (GRI), time in range, and a proprietary 'Sort by Change' capability that identifies patients whose glycemic status is rapidly deteriorating. The platform combines this software layer with wrap-around clinical services delivered by a team of Certified Diabetes Care and Education Specialists (CDCES), who perform monthly data reviews, patient outreach, and treatment coordination on behalf of the practice.

The business model is a no-upfront-fee practice partnership: SweetSpot charges no setup or monthly subscription, instead enabling practices to capture Remote Patient Monitoring (RPM) reimbursement through automated CPT code billing capture built into the platform. This aligns SweetSpot's revenue with the per-patient economics of remote care, which the company cites as roughly $1,000 in annual practice revenue per enrolled patient. Named partners include Jefferson City Medical Group (JCMG), DGD Clinic in San Antonio, and Diabetes & Endocrinology Specialists in Missouri; the company reports supporting thousands of patients nationwide as of late 2025. The leadership team combines clinical and commercial depth — CEO Stephen Von Rump (five-time CEO in health tech), CMO Dr. Ralph Oiknine (board-certified endocrinologist), CCO Abigail Cohen (Forbes 30 Under 30 Healthcare 2017), and board members including Dr. Mary Jo Gorman, founder of Advanced ICU Care.

As of September 2025, SweetSpot had reached $2M in annual recurring revenue and raised over $4M cumulatively, including a $1M+ seed round led by Cultivation Capital and a $4M round from BioGenerator and Cultivation Capital in January 2026. The company is positioning for a Series A in mid-2026 and has signaled continued expansion via a February 2026 strategic partnership with CCS (chronic care management platform) and ongoing AI feature development funded by the 2025 seed round.

SweetSpot firmographics

Firmographics
Name
SweetSpot
Legal name
Aegis Digital Health
Website
https://sweetspot.health
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
SweetSpot (Aegis Digital Health) provides a remote diabetes monitoring platform that aggregates CGM and insulin pump data into a unified dashboard, paired with CDCES-led clinical support services for endocrinology practices on a no-upfront-fee, reimbursement-aligned model.
Ownership category
akta.pro rank

SweetSpot industry classification

Industry
Product category
Remote Patient Monitoring Software
akta.pro industry
PRIMARYHLACAFAA
Chronic Disease RPM Platforms (Diabetes/HTN/COPD/CHF)
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLACAFAI
Care Coordination, Escalation & Clinical Workflow for RPM
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms

Keywords

  • Remote diabetes monitoring
  • CGM data management
  • Endocrinology software platform
  • Virtual clinical support
  • Insulin pump integration

Where SweetSpot is headquartered

Location

Headquarters

HQ city
St Louis
HQ country
United States
HQ region
North America

Offices2 records

Markets served

SweetSpot business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Remote Patient Monitoring Reimbursement: SweetSpot enables practices to capture reimbursable care events through automated CPT code utilization. Most health insurers including Medicare pay for monthly reviews and interpretation of patient glucose data. The platform automates data collection, review, and billing processes to unlock new revenue streams for practices.
  2. Clinical Support Services: Provides virtual team of Certified Diabetes Care and Education Specialists (CDCES) who perform monthly CGM data reviews and coordinate with providers on treatment plan changes. This wrap-around service is included in the practice partnership with no set-up or monthly subscription fees for providers.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyPractice Partnership - No upfront cost model

Go-to-market motion1 record

Distribution channels1 record

Marketing channels9 records

SweetSpot product offering

Product offering

Core offering

SweetSpot delivers a centralized software platform that aggregates continuous glucose monitor (CGM) and insulin pump data into a unified dashboard for endocrinology practices, combined with wrap-around virtual clinical support from Certified Diabetes Care and Education Specialists (CDCES) who conduct monthly data reviews, patient outreach, and treatment coordination. The platform enables practices to remotely monitor diabetes patients between visits, capture reimbursable remote care events through automated billing, and triage patients by change in Glycemia Risk Index.

Product overview

SweetSpot is a digital health platform combining centralized diabetes device data management software with virtual clinical support services. The core SweetSpot Remote Diabetes Monitoring Platform aggregates CGM and insulin pump data into a unified dashboard, which is paired with the SweetSpot Clinical Support Services module providing CDCES-led monthly data reviews, patient outreach, and treatment coordination. Additional modules include the Dashboard with Glycemia Risk Index (GRI) triage capabilities and Automated Billing Capture for reimbursement optimization. The platform integrates with major diabetes devices including Eversense 365, iLet Bionic Pancreas, and all major CGMs and insulin pumps.

Differentiator

Problem solved

Functional benefit

Products and services

  • SweetSpot Remote Diabetes Monitoring Platform A centralized software platform that aggregates and manages diabetes device data from continuous glucose monitors (CGMs) and insulin pumps, providing endocrinology practices with a single dashboard view of all patient data for remote monitoring between office visits. The platform integrates with all major CGMs and insulin pumps (including Eversense 365 and iLet Bionic Pancreas) and includes GRI-based triage, automated notes summary, and automated billing capture.
  • SweetSpot Clinical Support Services Wrap-around virtual clinical support services provided by a team of Certified Diabetes Care and Education Specialists (CDCES) who perform monthly CGM data reviews, patient outreach between visits, device troubleshooting, and coordinate treatment plan changes with the practice's providers. Delivered as part of the SweetSpot practice partnership with no set-up or monthly subscription fees to the practice.

Quantifiable outcome

  • 10%+ average improvement in Time in Range (TIR) per patient
  • +8 more outcomes

Companies that use SweetSpot

Customer profile

Named customers3 records

Segments1 record

Ideal customer profiles1 record

SweetSpot technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability4 records

Feature6 records

SweetSpot partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • CCS (Chronic Care Management Platform)coreStrategic or Co-development Partner · 10 February 2026Strategic partnership with CCS, a Florida-based chronic care management platform and provider of clinical solutions and home-delivered medical supplies for chronic conditions. The partnership connects SweetSpot's clinical team with CCS for supplies like CGM sensors, creating a coordinated feedback loop between platforms. SweetSpot's clinical team can directly connect patients experiencing adherence issues with CCS, leveraging CCS's national reach among private practices and AI capabilities like PropheSee adherence prediction tool. A pilot program launched in select U.S. markets in early 2026.
  • Beta Bionics (iLet Bionic Pancreas)coreTechnology or Integration · 1 January 2026Integration with iLet Bionic Pancreas from Beta Bionics. Device data flows directly into SweetSpot, viewable and manageable alongside other patients' information without separate logins or manual workarounds. This integration simplifies workflow for clinical teams managing patients on the iLet device.
  • Senseonics / Ascensia Diabetes CarecoreTechnology or Integration · 26 February 2025Software integration between SweetSpot and Eversense 365, the world's first and only One Year CGM system. The integration provides endocrinology practices partnering with SweetSpot the ability to seamlessly and regularly review data from patients using Eversense 365, allowing for more personalized support between scheduled appointments.

Scale indicators16 records

Recent moves6 records

Expansion highlights6 records

SweetSpot competitors and assessment

Company assessment

Direct peers

  • Glooko: Glooko provides a unified diabetes data management platform that aggregates data from most major CGMs, insulin pumps, and blood glucose meters for clinicians and patients—directly overlapping SweetSpot's core device-aggregation and remote-monitoring workflow for endocrinology practices.
  • Tidepool: Tidepool is a nonprofit diabetes data platform offering clinician-facing dashboards and reports across multiple CGM and pump devices. It overlaps with SweetSpot on multi-device data aggregation and clinical review, though it has not focused on reimbursement-bundled services.
  • mySugr (Roche Diabetes Care): mySugr, owned by Roche, offers a diabetes self-management app paired with clinician tools and is integrated with Roche's Accu-Chek ecosystem. It competes with SweetSpot for the same endocrinology practice relationships, especially in CGM-data review and patient engagement.
  • WellDoc: WellDoc's BlueStar is an FDA-cleared digital therapeutic for diabetes that delivers coaching and decision support to patients and integrates with clinician workflows—a directly comparable diabetes digital therapeutics and remote-care platform.
  • Virta Health: Virta Health is a virtual diabetes clinic combining continuous remote monitoring with clinician coaching to reverse type 2 diabetes. It targets the same payer/employer and endocrinology ecosystem and competes for remote-care reimbursement dollars.
  • Omada Health: Omada Health offers a virtual chronic-care platform including diabetes management with connected device integration, coaching, and reimbursement-based programs—closely matching SweetSpot's RPM-plus-coaching model for endocrinology and primary care.
  • Vida Health: Vida Health provides a virtual chronic-condition management platform spanning diabetes, hypertension, and mental health, with connected device integration and coaching—overlapping SweetSpot on RPM-led diabetes care for employer and payer populations.
  • Onduo (Verily): Onduo, part of Verily (Alphabet), is a virtual diabetes management program that combines CGM data with clinician coaching—targeting the same remote-monitoring and reimbursement-driven diabetes care segment as SweetSpot.

Broad incumbents

  • Livongo (Teladoc Health): Livongo, acquired by Teladoc, pioneered the connected CGM-plus-coaching diabetes program at scale and is now part of a much broader chronic-care portfolio. It is the category-defining incumbent against which all diabetes RPM entrants like SweetSpot are benchmarked.
  • Dexcom Clarity: Dexcom Clarity is the CGM manufacturer's own clinician analytics platform, aggregating Dexcom device data with reports for endocrinology practices. As a vertically integrated device-maker offering, it represents a structural competitive threat to SweetSpot's device-aggregation layer.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

SweetSpot social profiles

Digital presence

SweetSpot financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SweetSpot leadership team

Management profile

Number of profiles

Profiles12 records

SweetSpot funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SweetSpot M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SweetSpot

What does SweetSpot do?

SweetSpot delivers a centralized software platform that aggregates continuous glucose monitor (CGM) and insulin pump data into a unified dashboard for endocrinology practices, combined with wrap-around virtual clinical support from Certified Diabetes Care and Education Specialists (CDCES) who conduct monthly data reviews, patient outreach, and treatment coordination. The platform enables practices to remotely monitor diabetes patients between visits, capture reimbursable remote care events through automated billing, and triage patients by change in Glycemia Risk Index.

Is SweetSpot a public or private company?

SweetSpot is a private company. It is classified as venture growth investor backed and is currently operating.

When was SweetSpot founded?

SweetSpot was founded in 2021. It employs 11 to 50 people.

Where is SweetSpot based?

SweetSpot is headquartered in St Louis, United States, in the North America region.

How does SweetSpot make money?

Two revenue lines are on record. Remote Patient Monitoring Reimbursement is the primary driver. The others are clinical Support Services.

Who are SweetSpot's main competitors?

Direct peers on record are Glooko, Tidepool, mySugr (Roche Diabetes Care), WellDoc, Virta Health, Omada Health, Vida Health and Onduo (Verily). Broad incumbents are Livongo (Teladoc Health) and Dexcom Clarity.

Does SweetSpot have an API?

No public API is recorded for SweetSpot.

What industry is SweetSpot in?

SweetSpot's product category is Remote Patient Monitoring Software. Its primary akta.pro industry code is HLACAFAA, Chronic Disease RPM Platforms (Diabetes/HTN/COPD/CHF), with a secondary code of HLACAFAI, Care Coordination, Escalation & Clinical Workflow for RPM.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
St. Louis MagazineSt. Louis’ SweetSpot launches partnership with Florida company to help diabetes patientsSweetSpot, a St. Louis-based digital health startup, has formed a partnership with CCS, a Florida-based chronic care management platform, to improve diabetes patient care by addressing gaps in care continuity between device monitoring and supply management. The partnership enables SweetSpot's clinical team to directly connect patients experiencing adherence issues with CCS for supplies like continuous glucose monitor sensors, creating a coordinated feedback loop between the two platforms. SweetSpot expects this collaboration to significantly boost its sales pipeline and investor appeal by leveraging CCS's national reach among private practices and its existing AI capabilities like the PropheSee adherence prediction tool.American City Business JournalsSweetSpot raises $4M to scale diabetes remote monitoring platformHealthcare technology company SweetSpot has raised $4 million in funding from investors BioGenerator and Cultivation Capital to scale its remote monitoring platform for diabetes clinics. The platform enables clinics to capture and document reimbursable care activities that many practices currently underutilize. This funding represents a growth-stage investment for the diabetes care technology sector.SweetspotAegis Digital Health™ Secures $1M Seed Funding to Accelerate SweetSpot™ GrowthAegis Digital Health, operating as SweetSpot, raised over $1 million in seed funding led by Cultivation Capital. The company, with $2 million annual recurring revenue, will use the funds to scale operations and launch AI features. The round also fulfills a matching grant requirement.Stock TitanEversense 365 One-Year CGM System Integrates With SweetSpot Software for Enhanced Diabetes CareSenseonics and Ascensia announced software integration between SweetSpot and Eversense 365, the world's first one-year CGM system. The integration lets endocrinology practices review CGM data between appointments, enabling timely treatment adjustments and improved glycemic control.NasdaqSenseonics and Ascensia Announce Integration of SweetSpot Software with Eversense 365 CGM for Enhanced Diabetes Patient CareSenseonics and Ascensia announced a software integration between SweetSpot and the Eversense 365 CGM system in the U.S. The integration lets endocrinology practices review patient glucose data monthly and capture reimbursable care events. Eversense 365 is the only implantable CGM offering one year of monitoring.